Carcino Embryonic Antigen (CEA)
Biomarker blood monitoring test for bowel cancer
- At-home test
- Doctor reviewed
- Sample
- Blood
- Collection
- At-home finger-prick or Tasso autodraw or venous draw at clinic or nurse home visit
- Results in
- 1 day
- Biomarkers
- 1
- Doctor reviewed
- Yes
- Carcino Embryonic Antigen
Test specifications
- Provider
- Blue Horizon Medicals
- Sample type
- blood
- Collection method
- at-home finger-prick or Tasso autodraw or venous draw at clinic or nurse home visit
- Turnaround time
- 1 day
- Biomarkers tested
- 1
- At-home test
- Yes
- Doctor reviewed
- Yes
- Gender focus
- Both
What's tested
1 biomarker as listed by Blue Horizon Medicals.
- Carcino Embryonic Antigen
About this test
Carcino Embryonic Antigen (CEA) blood test is carried out to check for the return of colon and other cancers in those already diagnosed. It is not generally recommended as a screening test for cancer in the general population, but may be useful as part of a general investigation into suspected cancer in some individuals. It can be used to monitor the effectiveness of treatment and also the recurrence of disease. This test is usually tested before, during and after starting treatment.
Description provided by Blue Horizon Medicals.
More in Cancer screening
View all →Bowel Cancer Self-Test Kit
Early detection is key to effective treatment and management of bowel cancer. Our bowel cancer test kit offers a simple, non-invasive way to check for early signs of bowel cancer, allowing for prompt action if necessary.
- At-home test
Breast & Ovarian Cancer Risk
Some cancers run in families - knowing your risk can make all the difference. Up to 10% of breast cancers and up to 20% of ovarian cancers are linked to inherited genes.